tabl content
ndr jame
ndr inc
dinner apollo management apo
ndr alexand baldwin
ndr myovant scienc
ndr jame
ndr inc
ndr dover wellsit spin
ndr euronet rayna
ndr alexand baldwin
ndr jame
ndr inc
ndr dover wellsit spin
ndr alexand baldwin
meet ab/inbev bud
ndr dover wellsit spin
lunch brixmor samir
autonom ponder israel
walk away impact less
sever investor seem fear
coverag outperform
medic suppli devic initi coverag orthoped industri
autonom ponder israel
previou coverag mobiley travel israel sever time
past trip particularli special prepar dozen meet
decid re-read start-up nation stori israel econom miracl senor/
singer prime investig one passag struck particularli true
problem israel one command advantag sens purpos
isra may affluenc quiet life affluenc tend
cours three day met broad array excit early-stag
isra ai mobil startup vc govern agenc tel aviv culmin
alway invalu insight prof amnon shashua mobiley hq part
jerusalem meet found team focus/pass constant
remind uniqu isra sens purpos acut describ start-up nation
concept chutzpah question author rosh gadol big pictur think
bitzuist get done rich histori idf elit
militari elit thu fit host michael granoff maniv mobil sit
squar page vc must-read michael list one earliest
american isra auto investor shai agassi better place maniv sinc becom
one israel notabl seed-level mobil vc invest across
av/mobl ecosystem mike clearli man-to-know anyth futur mobil
come israel
walk away impact less sever
investor seem fear
earlier today bloomberg report start would use arm-
base cpu line comput step away
partnership note news report transit circul
almost decad time acquir ic asset incorpor
apple-design coprocessor machin suggest transit
improb clearli risk believ minor one
cpu like drive revenu see worst case ep impact
roughli transit immedi
includ increment baseband revenu big pictur understand
investor concern loss marque custom note loss
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest decis
ndr ford georg gallier
ndr
ndr ford georg gallier
ndr
lunch jone lang lasal
lunch silverlin privat
opportun healthcar
ndr adama
ndr umer
ndr umer
dinner transocean chmn
far certain loss would like gradual like retain
baseband busi appl stop use cpu would like
gradual final ep hit like compris less ep earli
like off-set oper improv
top-line growth elsewher reiter outperform rate price target
tough sled get easier resum coverag outperform
summari prior acquisit virgin america alaska rightli earn
reput high qualiti airlin strong reliabl custom loyalti high
rel margin sharehold friendli capit return integr virgin
challeng consum importantli compani transit
integr inning back optim support slower growth profil
addit cut year moder growth profil help alaska
begin recov high margin grow free cash flow resum coverag alaska
group outperform rate price target ep base
share
growthtegr high expect ltm share
trail xal airlin index -point -point last year
respect attribut under-perform integr challeng high
street vastli underestim much chang alaska absorb
acquisit virgin potenti chang competit environ
long would take compani get back root level
understand street optim like anchor alaska
reput team earn
compani transit back optim focu integr
agreement move singl reserv system expect april fulli
consum manag time near complet look backward
alaska result also impact effort claim relev
virgin exist custom base believ compani back
core focu -- run high qualiti airlin strong loyalti institution
follow period rapid growth claim virgin custom base alaska
moder growth rate tie-break us effort
relev new california custom base alaska sharpli increas new market
growth last year ad new market california
mani weak season demand period market matur improv
season help unit revenu trend start heal
goal grow free cash flow improv model
capital-expenditure vs compani activ manag free cash
potenti fee alignment/ segment believ compani take
harder look segment unbundl estim million
opportun per share bring change/ baggag fee in-lin
initi coverag orthoped industri
part coverag expans initi coverag orthoped sector
includ zimmer biomet ortho sector effect round
coverag larg cap med-tech
host webinar et click
summari industri view ortho sector fundament volum side
improv past year price pressur stabl continu remain level
seen industri also seen share shift within sever categori
net gainer share loser
see key theme shape industri
robot broader adopt continu tailwind given
first mover advantag
cjr bundl valu base care still pilot mode think price
pressur manag
consolid industri still fragment outsid larg joint reconstruct
like see consolid industri structur favor consolid
evrisi compani survey last week increas high
unemploy claim last week declin low
mfg pmi tick still record-high territori
debat rbi year tim horton brand
canada discuss seem reach crescendo last week
announc renov plan tim horton restaur
canada headlin cad usd spend rbi
franchise next four year seem like larg amount expect cost
closer usd per year net franchise renew fee dont see
departur rbi asset light model tim horton flattish comp
canada last year like pressur franchise margin franchise
remodel cost per unit cad doesnt seem oner given year
remodel cycl seem push year tim horton work
new format
daili monitor key event across global luxuri apparel footwear landscap
mall vacanc high
pipeston midstream deal phase montney valu realiz
saw eca deliv plan ambiti multi-year develop plan
montney infrastructur requir associ time capit requir
major hurdl field develop much canadian basin three
process plant tower sunris saturn deliv ahead schedul
budget support volum ramp margin uplift
key element invest case eca clear similar structur
midstream agreement pipeston would prioriti sour ga process
hydrogen sulfid carbon dioxid associ sulfur liquid ga higher cost
complex requir unlock higher condens yield associ
pipeston recal end eca struck similar agreement veresen
cn exist infrastructur lever long term agreement
midstream guarante volum return increment capit volum
certainti deal compris entireti dawson ga
gather compress facil plan mm expans
happi outcom agreement suspect templat
today announc acreag dedic revenu guarante reach full
capac today agreement clearli pave way valu realiz
pipeston broader montney eca liquid montney product
come pipeston rig current run sub basin
trump giveth trump taketh away
got higher volatil want extra volum come
cost weaker asset price concern market multipl futur deal
volumes/investor appetit sometim trend higher market volatil good januari
sometim high soon bad februari market start
strong still even februari volcano march trend lower
saw first quarter year march posit higher
ficc rate fx equiti deriv volum partli off-set lower invest bank
activ industri rev y/i declin across complet ecm dcm
march goe better trade softer i-bank wors asset price
moment investor much concern fallout
leadership trade war fear rise libor rate libor-oi spread
drive recent market declin question market multipl issu
alreadi overridden stock-specif thing happen quarter dont
look big move result day massiv liquid sidelin
improv global economi led basic everi dip sinc crisi bought
sustain bad volatil could advers impact convers healthi pipelin go
forward yet economi strong get littl worri
point think advers trend temporari thank strength
global economi low unemploy claim strong consum confid rise
moder inflat good compani fundament earn like surg
accord macro team strong balanc sheet cap market backdrop
still favor tax reform rate still low financ avail ceo confid
deliveri product figur expect next hr expect
releas deliveri product figur next hour consensu
deliveri expect factset model compani
collect model model
report model product run rate guidanc prior guidanc
model product end unit per week unit per
week report leak e-mail weekend ceo elon musk employe
suggest compani pass unit per week final week quarter
stock march yesterday fall short
weekli product target unit may weigh heavili might
otherwis done particularli given yesterday email leak direct
given market number inde week run-rat short unit
better believ expect clearli show progress vs
compani start year note bloomberg wide follow tracker
suggest run-rat closer unit week
initi price target
part roll-out orthoped sector initi coverag zimmer
biomet rate pt repres price upsid
current level pleas see link et webinar
brief summari rational
link et webinar click
summari thesi share trade meaning discount peer
market new ceo helm promis lead turnaround natur
question rate
high regard new ceo bryan hanson believ right
person job said think turnaround could take littl longer
new product like tailwind first need get around issu
resolv manufactur issu full resumpt suppli like push
sale reacceler like time frame
final much need invest turnaround busi like limit
oper leverag medium term
see ep grower medium term pt equat
blend price-to-earnings line recent trade level dcf impli
tgr
initi price target
part roll-out orthoped sector initi coverag
rate pt repres upsid current
level close pleas see link et webinar
brief summari rational
link et webinar
summari thesi backdrop great fundament acceler top line
continu momentum new product fair question ask stock
wouldnt continu work sidelin
ahead competit come new product launch
innov perhap best exemplifi mako think lead
hundr bp share gain next year
resolut recal contribut recent acquisit entellu
 novadaq grow well corpor provid confid
maintain hsd organ compound-annual-growth-rate mt
along modest om expans see consist high singl doubl
said alpha come last year coincid
acceler revenu growth aid multipl expans go forward see
revenu sustain current level would impli multipl either remain
current level possibl compress depend market given prefer
remain sidelin get better entri point
march auri health announc fda approv monarch flexibl
robot system system compet isrg flex cath system
expect approv next year cool video show system
work give indic system could look like
label thought auri system diagnost platform label note
could use therapeut option open pathway potenti
abl procedur line
 indic use monarch platform accessori intend
provid bronchoscop visual access patient airway
diagnost therapeut procedur
action
 give idea
 check show
flexibl system medgadget
multipl expans phase focu ep visibl upsid
challeng overal tape prove given high januari low
march one thing sure definit feel like multipl expans phase
bull market complet given dynam increasingli focus own
equiti notabl fundament upsid present fortun tool investor
see upsid core growth broadli thank china industri anticip modest
relief ralli post solid print highest convict lie within
see littl room error flip side see elev valuat within
cro complex modest downsid risk book biopharma given
take tactic cautiou stanc group turn downgrad view
iclr o/p lt thesi remain construct sole o/p rate
complex remain
downgrad
downgrad iclr in-lin due perceiv investor fear headlin risk
biopharma elev absolut valuat versu histor level provid
uninspir risk/reward profil note continu believ iclr manag
team best-in-class among long-term view fundament
remain gener unchang think express conserv view
industri sub-group vs iclr
call larg tactic look risk exposur among life scienc dx tool
gener find downsid risk space bit difficult one would think
strong secular tailwind support growth across geographi end market
howev believ risk tool current take less favor
view complex due mainli headlin issu associ biopharma
sell news overal see uptick biopharma much attent
paid larg custom iclr could lead choppi near-term
book growth could cap multipl expans core assumpt
iclr thesi
iclr lone out-perform group ytd vs flattish
elev valuat rel histori leav us upsid share
current level decent see better entri point come without meaning
capit alloc event open b/ notabl top-lin acceler challeng
see littl room continu multipl expans light biopharma
overhang wait potenti de-rat becom construct share thu
downgrad
happen final rule publish close polici chang
medicar advantag part implement requir share
drug rebat patient pharmaci point sale said would consid
respons novemb request inform futur rulemak topic
take provid increment detail might propos
futur year still appear intent requir po rebat point reiter
regulatori author also cite similar propos includ
white hous fiscal budget propos initi rfi like least one
factor prompt recent announc aet would
shift commerci employ risk book po rebat receiv public prais
hh secretari other like follow note plan sponsor
neutral po rebat premium increas econom other along
drug channel dont chang materi either step alon potenti
step toward drug price transpar bear watch also recal hh
secretari said march month administr would roll
whole slate propos lower drug price redirect discount
go middlemen patient instead
happen close post final rate announc
medicar advantag call call increas payment base
propos polici februari advanc notic compar
increas past two year improv driven bp
combin increas cost trend estim plu bp benefit
rebas counti ff cost estim note includ tailwind
anoth one-year moratorium health insur fee upward trend
risk code health plan estim add
reimburs averag
take increment posit rate updat adv plan icare-
focus particular strong improv alreadi high start point
advanc notic includ code trend hif moratorium medicar
advantag reimburs could next year note rebat math reabsorb
hif benefit code trend could less high estim
final rate reinforc administr support stanc toward overal
posit view growth prospect industri particular
see particularli strong setup stand-alone basi takeout option given
report talk altern detail breakdown
rate compon calcul benchmark chang compani
downgrad in-lin
downgrad rate in-lin follow today disappoint fda
updat drug activ like prove next ph fda
clarifi amend on-going ph fulfil exactli fda may need
see fda delay compress timelin amidst sever competitor
program make meaning progress depress space result
lower peak sale potenti probabl success
acknowledg model sensit peak sale forecast fulli
own program especi given fix cost base place updat valuat
weight across dcf pe
morn mulesoft file proxi statement regard pend acquisit
salesforc expect bear point lack competit bid
process fact essenti paid full price mule believ
intern mule project ahead street revenue help justifi
premium broader discuss crm new integr cloud
role bigger digit transform project acknowledg mule deal
relat dilut ebit ep could keep cap share near-
term mention broader tech overhang howev believ potenti
upsid deal look beyond underappreci
see recent pullback creat attract entri point long-term investor
reiter outperform pt
effort gain better understand current state busi upcom
plan equip purchas dentist survey nearli dental practic
second half march gener overal purchas intent total equip
next twelv month histor norm slightli read
howev current total revenu continu improv current level
last quarter read ask
largest impact current revenu dentist said patient volum
economi howev note past quarter increas
number particip begun mention lower insur reimburs
advers impact overal revenu
first time ask dentist use amazon particip
state use amazon least purchas suppli use
amazon averag purchas total suppli websit
ask percentag total suppli expect purchas amazon march
number rose
would like receiv survey go forward let us know email
follow subject pleas add
chart qqq set strong
qqq technolog remain strong posit absolut rel buy
 doubl bottom retest critic support remain intact
technolog like odd
fb bullish weekli revers critic support make stock strong buy
bullish revers day make stock trade buy min
remain strong rel absolut trend intact support
bullish weekli revers key support set doubl bottom
upsid
yield yr grind lower fals break-out bund test
crude ralli stiff resist wti/brent stock arent buy
either
ute rather buy ute yield eas crude resist
xlu multi-year support
dollar dxi remain weak usdjpi fight back bullish emfx firm mxn
em pois ralli brazil star em choppi start think
chang
downgrad in-lin
downgrad
trump giveth trump taketh away
trump giveth trump taketh away
trump giveth trump taketh away
trump giveth trump taketh away
trump giveth trump taketh away
trump giveth trump taketh away
initi price target
initi price target
research report excerpt herein certifi regul ac secur exchang act analyst primarili
respons said report follow chri mcnalli muse duan pfennigwerth vijay kumar ed hyman rich ross arndt ellinghorst kirk
isi research attest follow view render research report reflect person view subject compani
issuer part compens directli relat specif recommend view research report
analyst chri mcnalli arndt ellinghorst georg gallier non-u analyst contribut research report non-u analyst
may associ person evercor group therefor regist qualifi nyse finra research analyst
may subject finra rule restrict commun subject compani public appear trade secur
held analyst
